Found: 7
Select item for more details and to access through your institution.
Analysis of drug combinations: current methodological landscape.
- Published in:
- Pharmacology Research & Perspectives, 2015, v. 3, n. 3, p. 1, doi. 10.1002/prp2.149
- By:
- Publication type:
- Article
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 overexpression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
- Published in:
- Orphanet Journal of Rare Diseases, 2014, v. 9, n. 1, p. 282, doi. 10.1186/s13023-014-0201-x
- By:
- Publication type:
- Article
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
P3‐041: A POTENTIAL TRI‐THERAPY FOR ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P941, doi. 10.1016/j.jalz.2019.06.3067
- By:
- Publication type:
- Article
A COMBINATION OF ACAMPROSATE AND BACLOFEN (PXT864) SYNERGIZES WITH STANDARDS OF CARE FOR THE TREATMENT OF ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P948, doi. 10.1016/j.jalz.2017.06.1860
- By:
- Publication type:
- Article
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.
- Published in:
- Scientific Reports, 2015, p. 16084, doi. 10.1038/srep16084
- By:
- Publication type:
- Article
A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0169878
- By:
- Publication type:
- Article